In CAH, the wild-type CYP21A2 exons 2–10 could be integrated into intron 1, resulting in a fusion of the host exon 1 with the donor exons 2-10, which would allow correction for all downstream variants (7). The gene discussed is CYP21A2; the disease is congenital adrenal hyperplasia.